Raymond James Financial’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.77M Buy
44,007
+6,048
+16% +$774K ﹤0.01% 2602
2026
Q2
$7.19M Buy
37,959
+35,409
+1,389% +$5.25M ﹤0.01% 2437
2026
Q1
$237K Sell
2,550
-11,772
-82% -$1.04M ﹤0.01% 4794
2025
Q4
$1.15M Sell
14,322
-373
-3% -$31.2K ﹤0.01% 3688
2025
Q3
$1.43M Sell
14,695
-2,051
-12% -$165K ﹤0.01% 3430
2025
Q2
$1.17M Sell
16,746
-3,225
-16% -$184K ﹤0.01% 3471
2025
Q1
$992K Buy
19,971
+14,283
+251% +$903K ﹤0.01% 3499
2024
Q4
$397K Buy
+5,688
New +$472K ﹤0.01% 4034

Other funds holding ACLS

Raymond James Financial's ACLS Position: Q3 2026 in Review

Raymond James Financial increased its Axcelis (ACLS) stake by 16% in Q3 2026, buying an estimated $774K and bringing the position to 44,007 shares worth $5.77M. The position accounts for ﹤0.01% of the portfolio, ranked #2602.

Raymond James Financial first reported a position in ACLS in Q4 2024 and has held it in 8 quarters since. The position peaked at $7.19M in Q2 2026. 394 funds tracked by Wall St. Rank hold ACLS as of Q3 2026.

  • Raymond James Financial held 44,007 shares of Axcelis worth $5.77M as of Q3 2026.
  • Raymond James Financial bought 6,048 Axcelis shares in Q3 2026, an estimated $774K.
  • Axcelis made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #2602 holding.
  • Raymond James Financial first reported a position in Axcelis in Q4 2024 and has held it in 8 quarters since.
  • Raymond James Financial's Axcelis position peaked at $7.19M in Q2 2026.
  • 394 funds tracked by Wall St. Rank held Axcelis as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.